Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent manner

Journal of Biological Chemistry

Volumn 289, Issue 3, 2014, Pages 1457-1466

  Kawai, Masanobu ^a   Kinoshita, Saori ^a   Shimba, Shigeki ^b   Ozono, Keiichi ^c   Michigami, Toshimi ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCADIAN CLOCK; CIRCADIAN REGULATION; ISOPROTERENOL; LIGHT PHASE; NUTRITIONAL FACTORS; REGULATORY NETWORK; REPORTER ASSAY; SYMPATHETIC ACTIVITIES;

BODY FLUIDS; ELECTRIC CLOCKS; MAMMALS; METABOLISM; NUTRITION;

MUSCULOSKELETAL SYSTEM;

ADRENALIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CREATININE; CRYPTOCHROME 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBROBLAST GROWTH FACTOR 23; ISOPRENALINE; NUCLEAR RECEPTOR NR1D1; PHOSPHATE; PHOSPHORUS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SCLEROSTIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ARNTL PROTEIN, MOUSE; CRY1 PROTEIN, MOUSE; CRYPTOCHROME; FIBROBLAST GROWTH FACTOR; TRANSCRIPTION FACTOR ARNTL;

ADRENALIN URINE LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CREATININE URINE LEVEL; CRY1 GENE; DBP GENE; FGF23 GENE; FOOD INTAKE; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; METABOLIC REGULATION; MOUSE; NONHUMAN; PHOSPHATE METABOLISM; PHOSPHATE URINE LEVEL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; RANKL GENE; REV ERB ALPHA GENE; SOST GENE; SYMPATHETIC TONE; VITAMIN D METABOLISM; ADRENERGIC SYSTEM; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; OSTEOBLAST; PHYSIOLOGY; URINE;

ANIMALS; ARNTL TRANSCRIPTION FACTORS; CELL LINE; CIRCADIAN RHYTHM; CRYPTOCHROMES; EPINEPHRINE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; ISOPROTERENOL; MICE; MICE, KNOCKOUT; OSTEOBLASTS; PHOSPHATES; RESPONSE ELEMENTS; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS;

EID: 84892652149     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.500850     Document Type: Article

References (47)

1. Bergwitz, C., and Jüppner, H. (2011) Phosphate sensing. Adv. Chronic Kidney Dis. 18, 132-144
2. Razzaque, M. S. (2012) The role of Klotho in energy metabolism. Nat. Rev. Endocrinol. 8, 579-587
3. Hubbard, S. R., and Till, J. H. (2000) Protein-tyrosine kinase structure and function. Annu. Rev. Biochem. 69, 373-398
4. Quarles, L. D. (2012) Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat. Rev. Endocrinol. 8, 276-286
5. Martin, A., David, V., and Quarles, L. D. (2012) Regulation and function of the FGF23/Klotho endocrine pathways. Physiol. Rev. 92, 131-155
6. Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., and Yamashita, T. (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561-568 (Pubitemid 38542505)
7. Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., and Yamashita, T. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770-774 (Pubitemid 44949607)
8. Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., Iwasaki, H., Iida, A., Shiraki-Iida, T., Nishikawa, S., Nagai, R., and Nabeshima, Y. I. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45-51 (Pubitemid 27494749)
9. Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M. C., Moe, O. W., and Kuro-o, M. (2006) Regulation of fibroblast growth factor-23 signaling by Klotho. J. Biol. Chem. 281, 6120-6123 (Pubitemid 43847540)
10. ADHR Consortium. (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345-348
11. Feng, J. Q., Ward, L. M., Liu, S., Lu, Y., Xie, Y., Yuan, B., Yu, X., Rauch, F., Davis, S. I., Zhang, S., Rios, H., Drezner, M. K., Quarles, L. D., Bonewald, L. F., and White, K. E. (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat. Genet. 38, 1310-1315 (Pubitemid 44646294)
12. Lorenz-Depiereux, B., Schnabel, D., Tiosano, D., Häusler, G., and Strom, T. M. (2010) Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am. J. Hum. Genet. 86, 267-272
13. Liu, S., Tang, W., Zhou, J., Stubbs, J. R., Luo, Q., Pi, M., and Quarles, L. D. (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J. Am. Soc. Nephrol. 17, 1305-1315 (Pubitemid 43673410)
14. Shimada, T., Yamazaki, Y., Takahashi, M., Hasegawa, H., Urakawa, I., Oshima, T., Ono, K., Kakitani, M., Tomizuka, K., Fujita, T., Fukumoto, S., and Yamashita, T. (2005) VitaminDreceptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am. J. Physiol. Renal Physiol. 289, F1088 F1095 (Pubitemid 41447065)
15. Kolek, O. I., Hines, E. R., Jones, M. D., LeSueur, L. K., Lipko, M. A., Kiela, P. R., Collins, J. F., Haussler, M. R., and Ghishan, F. K. (2005) 1α,25-Dihydroxyvitamin D3 up-regulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G1036 G1042 (Pubitemid 41740608)
16. Nelson, W. (1964) Aspects of circadian periodic changes in phosphorus metabolism in mice. Am. J. Physiol. 206, 589-598
17. Carpenter, T. O., Insogna, K. L., Zhang, J. H., Ellis, B., Nieman, S., Simpson, C., Olear, E., and Gundberg, C. M. (2010) Circulating levels of soluble Klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J. Clin. Endocrinol. Metab. 95, E352 E357
18. Smith, E. R., Cai, M. M., McMahon, L. P., and Holt, S. G. (2012) Biological variability of plasma intact and C-terminal FGF23 measurements. J. Clin. Endocrinol. Metab. 97, 3357-3365
19. Vollmers, C., Gill, S., DiTacchio, L., Pulivarthy, S. R., Le, H. D., and Panda, S. (2009) Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression. Proc. Natl. Acad. Sci. U.S.A. 106, 21453-21458
20. Green, C. B., Takahashi, J. S., and Bass, J. (2008) The meter of metabolism. Cell 134, 728-742
21. Bass, J., and Takahashi, J. S. (2010) Circadian integration of metabolism and energetics. Science 330, 1349-1354
22. Liu, C., Li, S., Liu, T., Borjigin, J., and Lin, J. D. (2007) Transcriptional coactivator PGC-1α integrates the mammalian clock and energy metabolism. Nature 447, 477-481 (Pubitemid 46816732)
23. Damiola, F., Le Minh, N., Preitner, N., Kornmann, B., Fleury-Olela, F., and Schibler, U. (2000) Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 14, 2950-2961
24. Zhang, L., Abraham, D., Lin, S. T., Oster, H., Eichele, G., Fu, Y. H., and Ptáček, L. J. (2012) PKCγ participates in food entrainment by regulating BMAL1. Proc. Natl. Acad. Sci. U.S.A. 109, 20679-20684
25. Fagius, J., and Berne, C. (1994) Increase in muscle nerve sympathetic activity in humans after food intake. Clin. Sci. 86, 159-167 (Pubitemid 24056695)
26. Sakaguchi, T., Arase, K., Fisler, J. S., and Bray, G. A. (1988) Effect of starvation and food intake on sympathetic activity. Am. J. Physiol. 255, R284 R288
27. Troisi, R. J., Weiss, S. T., Parker, D. R., Sparrow, D., Young, J. B., and Landsberg, L. (1991) Relation of obesity and diet to sympathetic nervous system activity. Hypertension 17, 669-677
28. Tseng, Y. H., Cypess, A. M., and Kahn, C. R. (2010) Cellular bioenergetics as a target for obesity therapy. Nat. Rev. Drug Discov. 9, 465-482
29. Ralph, M. R., Foster, R. G., Davis, F. C., and Menaker, M. (1990) Transplanted suprachiasmatic nucleus determines circadian period. Science 247, 975-978
30. Kornmann, B., Schaad, O., Bujard, H., Takahashi, J. S., and Schibler, U. (2007) System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock. PLoS Biol. 5, e34
31. Shimba, S., Ogawa, T., Hitosugi, S., Ichihashi, Y., Nakadaira, Y., Kobayashi, M., Tezuka, M., Kosuge, Y., Ishige, K., Ito, Y., Komiyama, K., Okamatsu-Ogura, Y., Kimura, K., and Saito, M. (2011) Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation. PLoS One 6, e25231
32. Kondo, H., Nifuji, A., Takeda, S., Ezura, Y., Rittling, S. R., Denhardt, D. T., Nakashima, K., Karsenty, G., and Noda, M. (2005) Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J. Biol. Chem. 280, 30192-30200 (Pubitemid 41216198)
33. Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., and Karsenty, G. (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305-317 (Pubitemid 35345151)
34. Fu, L., Patel, M. S., Bradley, A., Wagner, E. F., and Karsenty, G. (2005) The molecular clock mediates leptin-regulated bone formation. Cell 122, 803-815 (Pubitemid 41242643)
35. Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., Clement, K., Vaisse, C., and Karsenty, G. (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434, 514-520 (Pubitemid 40477060)
36. Zhang, E. E., Liu, Y., Dentin, R., Pongsawakul, P. Y., Liu, A. C., Hirota, T., Nusinow, D. A., Sun, X., Landais, S., Kodama, Y., Brenner, D. A., Montminy, M., and Kay, S. A. (2010) Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat. Med. 16, 1152-1156
37. Lavi-Moshayoff, V., Wasserman, G., Meir, T., Silver, J., and Naveh-Many, T. (2010) PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am. J. Physiol. Renal Physiol. 299, F882 F889
38. Keller, H., and Kneissel, M. (2005) SOST is a target gene for PTH in bone. Bone 37, 148-158 (Pubitemid 40962421)
39. Benet-Pagès, A., Lorenz-Depiereux, B., Zischka, H., White, K. E., Econs, M. J., and Strom, T. M. (2004) FGF23 is processed by proprotein convertases but not by PHEX. Bone 35, 455-462 (Pubitemid 38953193)
40. Ito, N., Findlay, D. M., Anderson, P. H., Bonewald, L. F., and Atkins, G. J. (2013) Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells. J. Steroid Biochem. Mol. Biol. 136, 183-186
41. Larsson, T., Nisbeth, U., Ljunggren, O., Jüppner, H., and Jonsson, K. B. (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 64, 2272-2279 (Pubitemid 37449564)
42. Nishida, Y., Taketani, Y., Yamanaka-Okumura, H., Imamura, F., Taniguchi, A., Sato, T., Shuto, E., Nashiki, K., Arai, H., Yamamoto, H., and Takeda, E. (2006) Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int. 70, 2141-2147 (Pubitemid 44871378)
43. Perwad, F., Azam, N., Zhang, M. Y., Yamashita, T., Tenenhouse, H. S., and Portale, A. A. (2005) Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 146, 5358-5364 (Pubitemid 41653049)
44. Smith, B., Fang, H., Pan, Y., Walker, P. R., Famili, A. F., and Sikorska, M. (2007) Evolution of motif variants and positional bias of the cyclic-AMP response element. BMC Evol. Biol. 7, S15
45. Brown, W. W., Jüppner, H., Langman, C. B., Price, H., Farrow, E. G., White, K. E., and McCormick, K. L. (2009) Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia. J. Clin. Endocrinol. Metab. 94, 17-20
46. Samadfam, R., Richard, C., Nguyen-Yamamoto, L., Bolivar, I., and Goltzman, D. (2009) Bone formation regulates circulating concentrations of fibroblast growth factor 23. Endocrinology 150, 4835-4845
47. Saji, F., Shigematsu, T., Sakaguchi, T., Ohya, M., Orita, H., Maeda, Y., Ooura, M., Mima, T., and Negi, S. (2010) Fibroblast growth factor 23 production in bone is directly regulated by 1α,25-dihydroxyvitamin D, but not PTH. Am. J. Physiol. Renal Physiol. 299, F1212 F1217